BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 16199110)

  • 21. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
    Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
    Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccination with the recombinant major outer membrane protein elicits antibodies to the constant domains and induces cross-serovar protection against intranasal challenge with Chlamydia trachomatis.
    Tifrea DF; Ralli-Jain P; Pal S; de la Maza LM
    Infect Immun; 2013 May; 81(5):1741-50. PubMed ID: 23478318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
    Knight SC; Iqball S; Woods C; Stagg A; Ward ME; Tuffrey M
    Immunology; 1995 May; 85(1):8-15. PubMed ID: 7543450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
    Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
    J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge.
    Pal S; Barnhart KM; Wei Q; Abai AM; Peterson EM; de la Maza LM
    Vaccine; 1999 Feb; 17(5):459-65. PubMed ID: 10073724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
    McNeilly CL; Beagley KW; Moore RJ; Haring V; Timms P; Hafner LM
    Vaccine; 2007 Mar; 25(14):2643-55. PubMed ID: 17239501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cationic liposomal adjuvants CAF01 and CAF09 formulated with the major outer membrane protein elicit robust protection in mice against a Chlamydia muridarum respiratory challenge.
    Pal S; Tifrea DF; Follmann F; Andersen P; de la Maza LM
    Vaccine; 2017 Mar; 35(13):1705-1711. PubMed ID: 28238632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of immunodominant linear B-cell epitopes within the major outer membrane protein of Chlamydia trachomatis.
    Zhu S; Chen J; Zheng M; Gong W; Xue X; Li W; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2010 Nov; 42(11):771-8. PubMed ID: 20923859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal immunization induces long-term protection in mice against a Chlamydia trachomatis genital challenge.
    Pal S; Peterson EM; de la Maza LM
    Infect Immun; 1996 Dec; 64(12):5341-8. PubMed ID: 8945586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
    Pal S; Peterson EM; de la Maza LM
    Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
    Su H; Parnell M; Caldwell HD
    Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral immunization with chlamydial major outer membrane protein (MOMP).
    Taylor HR; Whittum-Hudson J; Schachter J; Caldwell HD; Prendergast RA
    Invest Ophthalmol Vis Sci; 1988 Dec; 29(12):1847-53. PubMed ID: 3192374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.
    Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dendritic cells (DCs) transfected with a recombinant adenovirus carrying chlamydial major outer membrane protein antigen elicit protective immune responses against genital tract challenge infection.
    Lü H; Wang H; Zhao HM; Zhao L; Chen Q; Qi M; Liu J; Yu H; Yu XP; Yang X; Zhao WM
    Biochem Cell Biol; 2010 Aug; 88(4):757-65. PubMed ID: 20651849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.
    Tifrea DF; Pal S; Popot JL; Cocco MJ; de la Maza LM
    J Immunol; 2014 Jun; 192(11):5201-13. PubMed ID: 24778450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A live and inactivated Chlamydia trachomatis mouse pneumonitis strain induces the maturation of dendritic cells that are phenotypically and immunologically distinct.
    Rey-Ladino J; Koochesfahani KM; Zaharik ML; Shen C; Brunham RC
    Infect Immun; 2005 Mar; 73(3):1568-77. PubMed ID: 15731055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Pal S; Bravo J; Peterson EM; de la Maza LM
    Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.